Skip to main content
KoBioLabs, Inc. logo

KoBioLabs, Inc. — Investor Relations & Filings

Ticker · 348150 ISIN · KR7348150004 KO Manufacturing
Filings indexed 174 across all filing types
Latest filing 2021-12-30 Capital/Financing Update
Country KR South Korea
Listing KO 348150

About KoBioLabs, Inc.

http://kobiolabs.com/en/

KoBioLabs, Inc. is a biotechnology company that develops innovative microbiome-based therapeutics. The company utilizes its proprietary Smartiome® platform, an integrated system for discovering novel drug candidates that employs AI-driven multi-omics analysis and a comprehensive microbiome library with a reverse-translation approach. KoBioLabs is focused on creating a pipeline of new drugs to treat a range of immune, metabolic, and brain disorders. The company also applies advanced technologies, including a microbe-based drug delivery system (mDDS) and biofoundry techniques, to enhance the efficacy of its treatments and address unmet medical needs.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시)(제2회차)
Capital/Financing Update Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) filing from GoBioLab, detailing the completion of a private placement of convertible bonds. This falls under the category of capital and financing updates, as it reports the finalization of a debt-based financing activity.
2021-12-30 Korean
증권발행결과(자율공시)(제3자배정-전환우선주)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party allocation of convertible preferred shares). It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2021-12-29 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the issuance of new shares (third-party allocation), the purpose of the funds, conversion rights, and the specific terms of the capital change. This falls under the category of announcements regarding new share issues or capital structure changes.
2021-12-21 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) by Kobiolabs. This is a standard regulatory filing in South Korea for companies listed on the KOSDAQ/KRX to disclose significant corporate events such as capital raising, debt issuance, or changes in capital structure. Since it details the terms of a specific financing activity (convertible bond issuance), it falls under the 'Capital/Financing Update' category.
2021-12-21 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the administrative procedure required for the meeting. Given the nature of the announcement as a regulatory disclosure of corporate action, it fits best under the RNS category.
2021-12-14 Korean
기타경영사항(특허권취득)(자율공시)(락토바실러스 플란타럼 KBL396 균주 및 그 용도-일본)
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure from a Korean company (KoBioLabs) regarding the acquisition of a patent in Japan. It is filed as a 'voluntary disclosure' (자율공시) concerning 'other management matters' (기타 경영사항). Since it does not fit into specific categories like financial reports, M&A, or director dealings, and is a standard regulatory announcement of a corporate event, it falls under the RNS (Regulatory Filings) category.
2021-12-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.